Barbara Frigerio
Milan, 20133, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Novel fully human IgG1 targeting folate receptor α demonstrates antitumor efficacy driven by avidity rather than monovalent binding affinity.
Journal: Scientific reports
Published: July 02, 2025
Role of antibody engineering in generation of derivatives starting from MOv19 MAb: 40 years of biological/therapeutic tools against folate receptor alfa.
Journal: Antibody therapeutics
Published: August 05, 2022
Validity of Anti-PSMA ScFvD2B as a Theranostic Tool: A Narrative-Focused Review.
Journal: Biomedicines
Published: October 19, 2021
A Bispecific Antibody to Link a TRAIL-Based Antitumor Approach to Immunotherapy.
Journal: Frontiers in immunology
Published: May 30, 2019
Folate receptors and transporters: biological role and diagnostic/therapeutic targets in cancer and other diseases.
Journal: Journal of experimental & clinical cancer research : CR
Published: January 28, 2019
Design, selection and optimization of an anti-TRAIL-R2/anti-CD3 bispecific antibody able to educate T cells to recognize and destroy cancer cells.
Journal: mAbs
Published: July 12, 2018
Effect of radiochemical modification on biodistribution of scFvD2B antibody fragment recognising prostate specific membrane antigen.
Journal: Immunology letters
Published: July 31, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026